Trial intelligence / Profile preview

Strepsils flavoured lozenge for dry and irritated sore throat

2010-020985-94Phase 3Completed

Sponsor
Reckitt
Start
Aug 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of amylmetacresol + 2,4-dichlorobenzyl alcohol in pharyngitis (2 arms), sponsored by Reckitt. Primary endpoint: Area under the change from baseline curve in severity of throat soreness from 0 to 2 hours. Started Aug 2010; status: completed.

02

Drugs

amylmetacresol + 2,4-dichlorobenzyl alcohol
03

Conditions

pharyngitis

Beyond the preview

Go deeper on 2010-020985-94.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-020985-94.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call